Variant analysis and interpretation for rare and undiagnosed genetic disease

Comprehensive and integrated technology optimized for genomic data

Current tools for rare variant analysis are fragmented, often involving several different pipelines that all require separate integration efforts and maintenance schedules. This disjointed framework prevents laboratories from scaling services effectively. Today, high-throughput labs need intuitive tools for variant calling, interpretation, and reporting in a comprehensive and seamless way.

The TruSight Software Suite (coming soon) consolidates all these tools at your fingertips. Simplify rare variant analysis and interpretation by calling, prioritizing, and reporting on variants from one software interface. The suite is designed for high-throughput labs using whole-genome sequencing to evaluate and report on variants associated with rare genetic disease.

Rare Variant Analysis Made Easy
Simplified Variant Annotation and Prioritization

Developed with input from leaders in genome interpretation of rare disease, the TruSight Software Suite automatically annotates variants and genes from multiple public databases, such as ClinVar, OMIM, and gnomAD. Additional options to upload custom annotations and query aggregated cases help you leverage institutional knowledge and learn from previous findings.

TruSight Software Suite also includes variant prioritization tools, including machine learning technology, to help corroborate results and sort on key variants. With intuitive interpretation and reporting options, you can filter variants via gene lists, inheritance modes, custom annotations, complex logic, and more.

Simplified Variant Annotation and Prioritization

Integrated Rare Variant Analysis Workflow

Save time and avoid the fragmented, multi-tool workflows common in rare variant analysis. The TruSight Software Suite supports seamless integration into an Illumina sequencing workflow, from accession to final reports. Jumpstart an automated analysis and interpretation pipeline and manage a single proband or up to five relatives within a single interface.

Secure Infrastructure for Variant Analysis

Centralizing multiple interpretation tools allows for consistent, robust compliance. TruSight Software Suite is ISO-27001 and ISO-13485 certified and complies with HIPAA (third party audited) and the principles of the GDPR. We also offer options to integrate with your lab’s single sign-on policy and other security settings.

How to Use TruSight Software Suite

See how easy it is to use the TruSight Software Suite to visualize, triage, and interpret rare variants. This use case description guides you through the complete workflow using an example data set.

Read Use Case
Alt Name

The TruSight Software Suite provides rapid turnaround for rare variant analysis with automated processing and joint variant calling. Powered by the speed and precision of the DRAGEN Platform,1 the suite performs comprehensive identification for key variant types, including:

  • Small variants
  • Copy number variants
  • Structural variants
  • Mitochondrial variants
  • Repeat expansions
  • Runs of homozygosity
  • Spinal muscular atrophy (SMA)

Integrated interpretation support is included for all variant classes. By analyzing and visualizing multiple types at one time, you can easily view compound heterozygosity across variant categories.

Variant Filtering and Prioritization

Rare Variant Analysis and Interpretation

Interested in the TruSight Software Suite? Complete the form and we’ll contact you with product updates and more information in advance of the product becoming available.
Landmark NGS Study Leads to National Sequencing Program

Sequencing infants with rare undiagnosed disease gives the SUREKids team an opportunity to find a possible genetic diagnosis for these children’s conditions.

Read Article
Driving Standards and Best Practices in Clinical Sequencing

The Medical Genome Initiative consortium aims to expand access to high-quality clinical whole-genome sequencing for rare genetic diseases.

Read Article
NGS for Rare Undiagnosed Genetic Disease Studies

A pioneer in his field, Dr. Murim Choi hopes to contribute to the diagnosis of rare disease patients who often present with puzzling symptoms.

Read Article
DRAGEN Bio-IT Platform
DRAGEN Bio-IT Platform

Perform accurate, ultra-rapid secondary analysis of sequencing data.

View Product
BaseSpace Sequence Hub
BaseSpace Sequence Hub

Simplify your bioinformatics with an economical, powerful computing environment to manage, analyze, and share data.

View Product
NovaSeq 6000 System
NovaSeq 6000 System

Get scalable throughput and flexibility for virtually any sequencing method, genome, and scale of project.

View System
Reference
  1. Miller NA, Farrow EG, Gibson M, et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med. 2015;7:100. doi: 10.1186/s13073-015-0221-8.